Siemens Buys Bayer Diagnostics, Becomes Third Largest IVD Company
This article was originally published in The Gray Sheet
Executive Summary
Siemens' purchase of Bayer's diagnostics division, under a $5.3 bil. deal announced June 29, will make it the third largest player in the in vitro diagnostics market behind Roche and Abbott
You may also be interested in...
Bayer Builds Cardiovascular Franchise With Possis Purchase
Bayer HealthCare will expand its cardiovascular device offerings by acquiring AngioJet thrombectomy system maker Possis Medical for $361 million under a deal announced Feb. 11
Bayer Builds Cardiovascular Franchise With Possis Purchase
Bayer HealthCare will expand its cardiovascular device offerings by acquiring AngioJet thrombectomy system maker Possis Medical for $361 million under a deal announced Feb. 11
Beckman Coulter Buys Cardiac Test Developer Biosite For $1.55 Billion
In a $1.55 billion acquisition plan announced March 25, Beckman Coulter looks to combine its strength as a leading manufacturer of lab instruments with the complementary expertise of diagnostic test developer Biosite